Trial Profile
A phase II trial of immunomodulatory progenitor cell therapy in Kawasaki disease
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 27 Jun 2017
Price :
$35
*
At a glance
- Drugs CLXR 001 (Primary)
- Indications Mucocutaneous lymph node syndrome
- Focus Therapeutic Use
- 27 Jun 2017 New trial record